Lifecore Biomedical, Inc. · NASDAQ:LFCR
22NW Fund, LP reported a 7.49% stake in Lifecore Biomedical, Inc. (Schedule 13D/A)
Event May 27, 2025 · Filed May 29, 2025
22NW Fund, LP reported a 7.49% stake in Lifecore Biomedical, Inc., 2,975,398 shares, with active intent on May 27, 2025. Filed May 29, 2025 (Schedule 13D/A).
- Stake
- 7.49%
- Shares
- 2,975,398
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| 22NW Fund, LP | 7.49% | 2,975,398 |
| 22NW, LP | 7.49% | 2,975,398 |
| 22NW Fund GP, LLC | 7.49% | 2,975,398 |
| 22NW GP, Inc. | 7.49% | 2,975,398 |
| Aron R. English | 7.49% | 2,975,398 |
| Bryson O. Hirai-Hadley | 0% | 583 |
| Nathaniel Calloway | 0% | 0 |
Source
Related
- Lifecore Biomedical, Inc.
- 22NW Fund, LP
- Lifecore Biomedical, Inc. shareholders
- Schedule 13D/A · 22NW Fund, LP · Jul 2, 2026
- Schedule 13D/A · 22NW Fund, LP · Dec 26, 2024
- Schedule 13D/A · Nelson Obus · Sep 29, 2026
- Schedule 13D/A · Legion Partners Asset Management, LLC · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13D/A · Legion Partners Asset Management, LLC · Jul 2, 2026
- Form 4 · Legion Partners, L.P. I · Jun 8, 2026